Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers — Boris Guyot | RDL Network
Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
Dataset en
Authors
BG
Boris Guyot
FC
Flora Clément
YD
Youenn Drouet
Abstract
1 min read
<p>Supplementary Table S4 shows the correlation between the ENI10 score and the IC50 of the indicated drugs in breast cancer cell lines from the "Genomics of Drug Sensitivity in Cancer Project".</p>
Discussion(0)
No comments yet. Be the first to comment.